John Ransom
Stock Analyst at Raymond James
(3.67)
# 743
Out of 4,876 analysts
227
Total ratings
64.65%
Success rate
15.3%
Average return
Main Sectors:
Stocks Rated by John Ransom
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CI The Cigna Group | Maintains: Strong Buy | $360 → $385 | $326.31 | +17.99% | 18 | May 5, 2025 | |
| UNH UnitedHealth Group | Reiterates: Strong Buy | $635 → $540 | $309.11 | +74.70% | 13 | Apr 21, 2025 | |
| RDNT RadNet | Upgrades: Strong Buy | $85 → $65 | $57.12 | +13.80% | 11 | Mar 5, 2025 | |
| HCA HCA Healthcare | Downgrades: Market Perform | n/a | $379.30 | - | 21 | Nov 22, 2024 | |
| THC Tenet Healthcare | Downgrades: Outperform | $195 | $173.63 | +12.31% | 17 | Nov 22, 2024 | |
| CYH Community Health Systems | Downgrades: Underperform | n/a | $3.39 | - | 8 | Nov 22, 2024 | |
| SCI Service Corporation International | Maintains: Outperform | $80 → $85 | $81.65 | +4.10% | 12 | Nov 1, 2024 | |
| GDRX GoodRx Holdings | Upgrades: Outperform | $10 | $4.90 | +104.08% | 2 | May 16, 2024 | |
| EHC Encompass Health | Reiterates: Strong Buy | $85 → $95 | $122.20 | -22.26% | 15 | Apr 26, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Market Perform | n/a | $11.45 | - | 7 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | n/a | $97.92 | - | 14 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $241.88 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $20.41 | -2.01% | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $25 → $30 | $28.44 | +5.49% | 12 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $10 → $12 | $13.85 | -13.36% | 9 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $68.49 | +24.11% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $105 | $115.12 | -8.79% | 8 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $10 | $4.90 | +104.08% | 4 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $5.02 | - | 7 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $3.81 | - | 11 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $21.58 | - | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $85 → $100 | $21.90 | +356.62% | 8 | Aug 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $56.00 | - | 2 | Feb 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $27.54 | - | 2 | Dec 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $141.67 | - | 8 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $21.95 | - | 2 | Aug 9, 2017 |
The Cigna Group
May 5, 2025
Maintains: Strong Buy
Price Target: $360 → $385
Current: $326.31
Upside: +17.99%
UnitedHealth Group
Apr 21, 2025
Reiterates: Strong Buy
Price Target: $635 → $540
Current: $309.11
Upside: +74.70%
RadNet
Mar 5, 2025
Upgrades: Strong Buy
Price Target: $85 → $65
Current: $57.12
Upside: +13.80%
HCA Healthcare
Nov 22, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $379.30
Upside: -
Tenet Healthcare
Nov 22, 2024
Downgrades: Outperform
Price Target: $195
Current: $173.63
Upside: +12.31%
Community Health Systems
Nov 22, 2024
Downgrades: Underperform
Price Target: n/a
Current: $3.39
Upside: -
Service Corporation International
Nov 1, 2024
Maintains: Outperform
Price Target: $80 → $85
Current: $81.65
Upside: +4.10%
GoodRx Holdings
May 16, 2024
Upgrades: Outperform
Price Target: $10
Current: $4.90
Upside: +104.08%
Encompass Health
Apr 26, 2024
Reiterates: Strong Buy
Price Target: $85 → $95
Current: $122.20
Upside: -22.26%
Walgreens Boots Alliance
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $11.45
Upside: -
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $97.92
Upside: -
Mar 22, 2024
Initiates: Market Perform
Price Target: n/a
Current: $241.88
Upside: -
Mar 22, 2024
Initiates: Outperform
Price Target: $20
Current: $20.41
Upside: -2.01%
Mar 15, 2024
Reiterates: Outperform
Price Target: $25 → $30
Current: $28.44
Upside: +5.49%
Jan 9, 2024
Maintains: Strong Buy
Price Target: $10 → $12
Current: $13.85
Upside: -13.36%
Aug 4, 2023
Maintains: Outperform
Price Target: $90 → $85
Current: $68.49
Upside: +24.11%
Aug 2, 2023
Maintains: Outperform
Price Target: $100 → $105
Current: $115.12
Upside: -8.79%
Aug 1, 2023
Maintains: Outperform
Price Target: $8 → $10
Current: $4.90
Upside: +104.08%
May 12, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $5.02
Upside: -
May 10, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $3.81
Upside: -
May 3, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $21.58
Upside: -
Aug 1, 2022
Maintains: Strong Buy
Price Target: $85 → $100
Current: $21.90
Upside: +356.62%
Feb 14, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $56.00
Upside: -
Dec 20, 2019
Initiates: Market Perform
Price Target: n/a
Current: $27.54
Upside: -
Nov 7, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $141.67
Upside: -
Aug 9, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $21.95
Upside: -